期刊文献+

人流术后放置曼月乐与新体380的临床效果对照分析 被引量:2

Comparative Analysis of Clinical Effect of Mirena and New Body 380 After Abortion
下载PDF
导出
摘要 目的探讨曼月乐与新体380的避孕效果及不良反应发生率。方法选取我院2014年6月—2014年12月于计划生育门诊接收并要求进行人流后放置宫内节育的已婚妇女300例作为研究对象,按照对象节育要求,将其划分为观察组和对照组,观察组采用曼月乐节育方式避孕;对照组使用新体380避孕。随访一年,对两组对象的避孕效果和不良反应进行比较。结果曼月乐组闭经率为30.0%,出血率为2.21%,因病症取出率为2.21%,带器妊娠率为0;新体380出血率为7.49%,带器妊娠率和过敏率是0.82%,因病症取出率为8.32%,闭经率为0。曼月组出血率及因病症取出率明显低于新体380组,差异显著具有统计学意义,(P<0.05)。结论两组宫内节育器材均可获得良好的避孕效果,但曼月乐比新体380副作用低、满意度高、接受性高,是目前宫内避孕比较常用的节育方法,值得在临床上推广应用。 Objective To investigate the contraceptive effect and adverse reactions incidence rate of Mirena and new body 380. Methods 300 cases of married women treated in our hospital from June 2014 to December 2014 after the placement of intrauterine device were selected as the research object. According to the requ/rements of the object, they were divided into the observation group and the control group. The observation group used contraceptive contraception control group us Mirena 380 new contraceptive. Contraceptive effect and adverse reactions were compared between the two groups during one year follow-up. Results Mirena group amenorrhea rate was 30.0%, the bleeding rate was 2.21%, due to disorder of removal rate of 2.21%, with pregnancy rate was 0; new 380 bleeding rate was 7.49%, with pregnancy rate and the rate of allergies was 0.82%, due to illness removed rate was 8.32%, and the amenorrhea rate was 0. The rate of bleeding and the rate of removal of the disease in the group of 380 groups were significantly lower than that of the new body group, the difference was statistically significant (P〈0.05). Conclusion Two groups of intrauterine contraceptive device can obtain good contraceptive effect, but the side effect of Mirena is lower than the new body 380 , has high satisfaction, accept. It is commonly used in the current intrauterine contraceptive method, it is worth of clinical application.
出处 《新疆医学》 2017年第1期78-80,共3页 Xinjiang Medical Journal
关键词 宫内节育器 曼月乐 新体380 IUD Mirena New Body 380
  • 相关文献

参考文献5

二级参考文献40

  • 1盛洁,卢丹,张建萍,崔桂芬.左炔诺孕酮宫内释放系统治疗子宫腺肌病痛经的临床观察[J].中华妇产科杂志,2006,41(7):467-470. 被引量:83
  • 2邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量:113
  • 3魏丽娜,祁秀娟,赵文翠,段玉英,吕映频.左炔诺孕酮宫内缓释系统治疗子宫腺肌病疗效观察[J].中国实用妇科与产科杂志,2007,23(3):192-194. 被引量:48
  • 4Andersson K,Odlind V,Rybo G,et al.Levonorgestrel-releasing and copper-releasing(Nova T)IUDs during five years of use:a randomized comparative trial.Contraception,1994,49:56-72.
  • 5Luukkmnen T,Pakarinen P,Toivonen J.Progestin-releasing intrauterine system.Semi Reprod Med,2001,19:355-363.
  • 6Petta CA,Ferriani RA,Abrao MS et al.A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel releasing intrauterine system[J].Eur J Obstet Gynecol Reprod Biol,2009,143(2):128.
  • 7Ferreira RA,Vieira CS,Rosa-E-Silva JC et al.Effects of the levonorgestrel-releasing intrauterine system on cardiovas-cular risk markers in patients with endometriosis:a comparative study with the GnRH analogue[J].Contraception,2010,81(2):117.
  • 8Crosiqnani PG,Luciano A,Ray A et al.Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain[J].Hum Re-prod,2006,21(1):248.
  • 9Mcgaviqan CJ,Dockery P,Metaxa-Mariaton V et al.Horm-onally mediated disturbance of angiogenesis in the human endo-metrium after exposure to intrauterine levonorgestrel[J].Hum Reprod,2003,18(3):77.
  • 10Kar S,Rees RG,Quirion R.Altered calcitonin gene-related peptide,substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyar-thritic rat[J].Eur J Neurosci,1994,6(4):347.

共引文献125

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部